Table 5.

Bone Marrow Findings Before and After CSA Therapy

Patient 1Patient 2 Patient 3
PrePost Pre Post Pre Post
Cellularity (%)  80 50  20  70  20  20  
Lymphocytes (%)  77  67 29  17  50  24  
Lymphocyte mass4-150 62  34  12 6  10  5  
Granulocytes (%)  6  14  6  12 4  6  
Granulocyte mass4-150 5  7  1  4  1  
Erythroid cells (%)  10  17  63  25  25  54 
M:E ratio  1:2  1:1  1:16  1:4 1:5  1:5  
Megakaryocytes4-151 1  2  5  10  
Patient 1Patient 2 Patient 3
PrePost Pre Post Pre Post
Cellularity (%)  80 50  20  70  20  20  
Lymphocytes (%)  77  67 29  17  50  24  
Lymphocyte mass4-150 62  34  12 6  10  5  
Granulocytes (%)  6  14  6  12 4  6  
Granulocyte mass4-150 5  7  1  4  1  
Erythroid cells (%)  10  17  63  25  25  54 
M:E ratio  1:2  1:1  1:16  1:4 1:5  1:5  
Megakaryocytes4-151 1  2  5  10  

Abbreviations: M, myeloid; E, erythroid.

F4-150

Derived by multiplying the average cellularity of the bone marrow biopsy section by the corresponding cell percentage determined on marrow aspirate smear.

F4-151

Average per high-power field.

or Create an Account

Close Modal
Close Modal